Veronique Duke

1.7k total citations
22 papers, 923 citations indexed

About

Veronique Duke is a scholar working on Molecular Biology, Genetics and Reproductive Medicine. According to data from OpenAlex, Veronique Duke has authored 22 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Reproductive Medicine. Recurrent topics in Veronique Duke's work include Hypothalamic control of reproductive hormones (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Veronique Duke is often cited by papers focused on Hypothalamic control of reproductive hormones (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Veronique Duke collaborates with scholars based in United Kingdom, United States and Greece. Veronique Duke's co-authors include Letizia Foroni, Richard Quinton, Jeremy Kirk, P A de Zoysa, Howard S. Jacobs, Bella Patel, G. M. Besser, Pierre Bouloux, Pierre-Marc Bouloux and David C. Linch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Veronique Duke

22 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronique Duke United Kingdom 14 384 299 247 209 202 22 923
Sílvia R.P. Miranda United States 11 492 1.3× 189 0.6× 260 1.1× 88 0.4× 46 0.2× 19 970
Beatrice B. Yaroslavskiy United States 15 681 1.8× 153 0.5× 88 0.4× 99 0.5× 234 1.2× 21 1.3k
J.H.A.M. Tuerlings Netherlands 18 440 1.1× 210 0.7× 72 0.3× 34 0.2× 453 2.2× 49 880
Michael H. Guo United States 20 603 1.6× 76 0.3× 27 0.1× 37 0.2× 509 2.5× 33 1.2k
Charlie Degui Chen China 18 1.3k 3.3× 73 0.2× 86 0.3× 35 0.2× 185 0.9× 31 1.5k
Alma Kuechler Germany 19 649 1.7× 25 0.1× 60 0.2× 44 0.2× 722 3.6× 46 1.2k
Giulia Arrigo Italy 12 339 0.9× 56 0.2× 121 0.5× 27 0.1× 240 1.2× 21 594
Rachel Larder United Kingdom 14 480 1.3× 108 0.4× 70 0.3× 23 0.1× 288 1.4× 19 997
Sibylle Jakubiczka Germany 21 814 2.1× 137 0.5× 48 0.2× 14 0.1× 606 3.0× 54 1.4k
Ankie Strik United States 4 242 0.6× 221 0.7× 231 0.9× 11 0.1× 79 0.4× 9 642

Countries citing papers authored by Veronique Duke

Since Specialization
Citations

This map shows the geographic impact of Veronique Duke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronique Duke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronique Duke more than expected).

Fields of papers citing papers by Veronique Duke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronique Duke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronique Duke. The network helps show where Veronique Duke may publish in the future.

Co-authorship network of co-authors of Veronique Duke

This figure shows the co-authorship network connecting the top 25 collaborators of Veronique Duke. A scholar is included among the top collaborators of Veronique Duke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronique Duke. Veronique Duke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansour, Marc R., Maria Luisa Sulis, Veronique Duke, et al.. (2009). Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. Journal of Clinical Oncology. 27(26). 4352–4356. 81 indexed citations
2.
Patel, Bella, Lena Rai, Georgina Buck, et al.. (2009). Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993. British Journal of Haematology. 148(1). 80–89. 107 indexed citations
3.
Steele, Andrew J., A. G. Prentice, A. Victor Hoffbrand, et al.. (2008). p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood. 112(9). 3827–3834. 55 indexed citations
4.
Goulding, Carol, Ben Uttenthal, Letizia Foroni, et al.. (2007). The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis. International Journal of Laboratory Hematology. 30(5). 415–419. 25 indexed citations
5.
Mansour, Marc R., Veronique Duke, Letizia Foroni, et al.. (2007). Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 13(23). 6964–6969. 60 indexed citations
6.
Steele, Andrew J., Dylan T. Jones, K. Ganeshaguru, et al.. (2006). The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia. 20(6). 1073–1079. 63 indexed citations
7.
Porakishvili, Nino, Andrew P. Jewell, Pierre Youinou, et al.. (2005). Differential expression of CD180 and IgM by B‐cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes. British Journal of Haematology. 131(3). 313–319. 23 indexed citations
8.
Folarin, Najeem, Robert J. Baker, Veronique Duke, et al.. (2004). Zap-70 and IgVH Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.. Blood. 104(11). 1907–1907. 1 indexed citations
9.
Hughes, Derralynn, et al.. (2004). High Prevalence of B-Cell Clonality in Patients with Gaucher’s Disease.. Blood. 104(11). 2391–2391. 3 indexed citations
10.
Rowntree, Clare, Veronique Duke, Panayiotis Panayiotidis, et al.. (2002). Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia. 16(7). 1267–1275. 17 indexed citations
11.
Quinton, Richard, Veronique Duke, Alexis Robertson, et al.. (2001). Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization*. Clinical Endocrinology. 55(2). 163–174. 162 indexed citations
12.
Duke, Veronique, et al.. (2000). BCL10 deletions in haematological malignancies: a cloning artefact?. British Journal of Haematology. 111(4). 1106–1108. 4 indexed citations
13.
Jackson, Adam, Paola Carrara, Veronique Duke, et al.. (2000). Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.. PubMed. 60(11). 2775–9. 45 indexed citations
14.
Duke, Veronique. (1998). Proteinuria, hypertension and chronic renal failure in X-linked Kallmann's syndrome, a defined genetic cause of solitary functioning kidney. Nephrology Dialysis Transplantation. 13(8). 1998–2003. 31 indexed citations
15.
Zoysa, P A de, Rachel J. A. Helliwell, Veronique Duke, Richard Quinton, & Pierre-Marc Bouloux. (1998). Contrasting Expression ofKALin Cell-Free Systems: 5′ UTR and Coding Region Structural Effects on Translation. Protein Expression and Purification. 13(2). 235–242. 3 indexed citations
16.
Quinton, Richard, Julia Schofield, Veronique Duke, et al.. (1997). X-linked ichthyosis with hypogonadism: not always Kallmann's syndrome. Clinical and Experimental Dermatology. 22(4). 201–204. 8 indexed citations
17.
Quinton, Richard, Veronique Duke, P A de Zoysa, et al.. (1996). The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis.. The Journal of Clinical Endocrinology & Metabolism. 81(8). 3010–3017. 135 indexed citations
18.
Duke, Veronique, Paul J.D. Winyard, Peter Thorogood, et al.. (1995). KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Molecular and Cellular Endocrinology. 110(1-2). 73–79. 78 indexed citations
19.
Bouloux, Pierre-Marc, Veronique Duke, Margaret Hall‐Craggs, et al.. (1994). Kallmannʼs syndrome. Current Opinion in Obstetrics & Gynecology. 6(3). 301–301. 3 indexed citations
20.
Kirk, Jeremy, Patricia B. Munroe, Veronique Duke, et al.. (1993). Deletion analysis maps ocular albinism proximal to the steroid sulphatase locus. Clinical Genetics. 43(4). 169–173. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026